Adherence to commercial food thickener in patients with oropharyngeal dysphagia.

BACKGROUND: Oropharyngeal dysphagia (OD), a common symptom in the elderly, uses commercial thickener (CT) as part of its treatment. This is often accompanied of dislike and poor compliance. AIM: Describe adherence to CT and possible differences according to dwelling location in an area of influence of approximately 400.0000 inhabitants. METHODS: Cohort prospective observational study. Randomized patients from Nutrition and Dietetic (NDU)-database (4 calls-interviews/year). VARIABLES: Age, diagnostic, gender, dwelling/location: Home (H) / Nursing Home (NH), viscosity (nectar, honey, pudding), days with CT. Adherence measured with a questionnaire, considering implementation of treatment by combining CT use and consumption data, categorised in three groups good, moderate and poor. Change in patterns (improvement, maintenance, worsening) and non-adherence reasons. RESULTS: One hundred sixty-eight patients recruited with indicated viscosity: Nectar 39.7%, honey 29.3% and pudding 30.8%. Average age of 82.6 ± 11.1 years; 57.8% women (46.4% at H vs. 67% at NH, p < 0.01). Dwelling/location: 80 (47.6%) live at H and 88 (52.4%) at NH. Days with CT prior study were 509 ± 475.28. Implementation found in first call: good in 50%, moderate in 20.2% and poor in 29.8%. At first call, adherence parameters were more favourable in NH compared to H. However these parameters were reversed during the study period as there was an improvement at H vs. NH. Also in terms of change in patterns a significant improvement of implementation was found in patients living at H, 31.1% vs. those living at NH, 15.7%, p < 0.05. CT persistence throughout study was 89.7%. CONCLUSIONS: Low adherence to CT found in our community. Telephone follow-up resulted in improved adherence, especially in the H population. Our data provides valuable insights into the variability and changes in CT adherence among patients with OD. Adherence is complex and subject to many factors and dwelling/location is one of them. This study reveals the need to approach CT treatment for OD differently in NH.

Differences in the use of food textures in oropharyngeal dysphagia according to the place of living.

BACKGROUND&AIMS: Modifying solid/liquid foods is the main treatment in oropharyngeal dysphagia (OD). Commercial Thickener (CT) for treatment is subsidized by health system and is delivered to patient's place of living, once is managed by our hospital Nutrition-Dietetics Unit (NDU). AIM: To describe the patterns of texture for foods/liquids follow in patients with OD who are treated with CT. METHODS: Cohort prospective study. Randomized patients from NDU-database followed throughout 2018 (4 calls-interviews/year). Variables; age, diagnostic, gender, residence type: Home(H)/Nursing Home(NH), thickener manager (patient, family member or caregiver), education, days with commercial thickener (CT), thickener regimen established by Volume/Viscosity test: nectar (N), honey (HY), pudding (P), type of diets; measured by FOIS scale and texture; pureed (PD); soft (SD); mixed (P&S/D); regular (RD), risk foods consumption (RFC), complete diet intake (CI), changes in; diets, intake and RFC. RESULTS: Analysed 204 patients, aged 85 years; (IQR: 78-90), from which 57.8% were women. Residence: 43.6% H/56.4% NH. Days with CT median 380 days (IQR: 153-682). A proper viscosity guideline was indicated in 168 patients: N 37.3%, HY 20.6% and P 24.5%. In 36 patients (17.5%) there were no indications, 75% of them coming from primary care. Despite this, 184 patients (90%) referred a concrete indication; N 35.8%, HY 26% and P 28.4%. The concordance between indicated and referred viscosity was significantly higher at H (Kappa 0.798) compared to NH (Kappa 0.428), p < 0.0001. FOIS: 65.7% followed the total oral diet of a single consistency. Diet textures: PD 66.7%, SD 2.9%, P&S/D 21.1%, RD 9.3%. Difference in PD given in NH 86.1% vs H 41.6%, p < 0.001. Under N viscosity different diet distributions, PD 28.6%H vs 71% NH, p < 0.05. CI in 66.7% with no difference among NH/H. RFC similar but higher consumption of jellies at NH, p < 0.001. CONCLUSIONS: According to this study the place of living determines a better approach to OD treatment. Viscosity and diet texture are more restricted in NH with worse compliance of indicated regimens. Increasing variety in diets and reassessment of OD treatment is desirable.

[Differences in the quality of life of patients with oropharyngeal dysphagia according to the place of residence: impact on food selection and type of diet]. / Diferencias en la calidad de vida de pacientes con disfagia orofaríngea según el lugar de residencia: impacto en la selección de alimentos y el tipo de dieta.

INTRODUCTION: Background: dysphagia is a disabling, uncomfortable symptom with repercussions on daily basic aspects of well-being. The SWAL-QoL test is validated for checking dysphagia's impact on quality of life (QoL). Methods: a descriptive cross-sectional study. Randomized patients from our in-house Nutrition & Dietetics database. Telephone interviews directly with patients or caregivers. SWAL-QoL test, 11 sections: swallowing, eating, symptoms, food selection, communication, fears, mental health, fatigue, and social function. A 1-5 Likert scale was adjusted and final results were linearly transferred to 0-100 (100 being best positive score). Results as follows: 0-49 severe impact (SI), 50-70 moderate impact (MI), and 71-100 mild impact or no impact (DI/NI). Variables: gender, age, days with treatment, residence: Home (H)/nursing home (NH), indication of commercial thickener (CT) by V/V test: nectar (N), honey (H), pudding (P), days with CT, type of diets; pureed (PD), soft diet (SD), mixed(P&S/D), regular (RD), SWAL-QoL sections. Results: a total of 202 patients with a mean age of 85 years (23-103); IQR: 12. Mostly women, 57.9 %. Dwelling: 43.1 % H/56.9 % NH. SWAL-QoL: SI affects 19.3 %, 59.9 % MI and 20.8 % DI/NI. Using less thickener proved a better QoL; SI in pudding 21.1 % vs nectar 15.3 %, p = 0.04. Diets included 66.3 % PD; 3 % SD; MD, 21.3 %, and RD, 9.4 %. At NH 86.1 % of PD vs 40.2 % at H, p < 0.001. Direct impact of diet on QoL: 30.8 % on DI or no impact of grouped diets vs 15.7 % with PD, p = 0.016. Analysing each section by H/NH, significant difference between fears, higher at H, 57.01 ± 36.41 vs NH, 48.70 ± 27.03, p < 0.001; worse mental health for NH, 66.44 ± 34.30 vs H, 47.48 ± 24.06, p < 0.001; better food selection for H, 75.86 ± 34.12 vs NH, 68.17 ± 33.60, p < 0.01. Conclusions: defining QoL contributes to a better understanding of patient needs. More information to confront their fears is helpful to adjust the texture of liquids properly. Increasing adaptations of diets and diversity in food selection are needed especially in those living in NH.

INTRODUCCIÓN: Introducción: la disfagia es un síntoma invalidante, incómodo, con repercusiones en aspectos básicos del bienestar. El test SWAL-QoL esta validado para comprobar el impacto de la disfagia en la calidad de vida (QoL). Métodos: estudio descriptivo transversal (enero 2018). Pacientes con tratamiento de espesante aleatorizados a partir de la base de datos interna de la Unidad de Nutrición y Dietética. Entrevistas telefónicas al paciente o cuidador. Test SWAL-QoL, 11 secciones: carga de enfermedad, síntomas, selección de alimentos, apetito, duración comidas, miedos, comunicación, salud mental, sueño/descanso, fatiga y afectación social. Puntuación ajustada con escala Likert (1-5). Resultados finales transferidos linealmente de 0 a 100 (mejor puntuación positiva). Interpretación: 0-49, impacto severo (IS); 50-70, impacto moderado (IM); y 71-100, impacto discreto o sin impacto (ID/NI). Variables: sexo, edad, días de tratamiento, vivienda en domicilio (D)/residencia(R); indicación de espesante comercial (EC) con MECV-V: néctar (N), miel (M), pudín (P); días con EC, tipo de dieta: puré (DP), blanda (SD), mixta (DM), normal (DN); secciones SWAL-QoL. Resultados: en total, 202 pacientes de 85 años (23-103); IQR: 12. Mayoría de mujeres, 57,9 %; 43,1 % D/56,9 % R. SWAL-QoL: 19,3 % IS, 59,9 % IM y 20,8 % ID/NI. Usar menos espesante demostró mejor QoL, IS en pudín: 21,1 % vs. Néctar: 15,3 %, p = 0,04. Las dietas realizadas fueron: 66,3 % DP; 3 % DB; DM 21,3 %, y DN 9,4 %. En R, más DP (86,1 %) que en D (40,2 %), p < 0,001. DP asociada a peor QoL: % de ID o no impacto en DP, 15,7 % vs. 30,8 % en el resto de dietas, p = 0,016. Analizando cada sección por D/R, diferencia significativa entre miedos, mayor en D (57,01 ± 36,41) vs. R (48,70 ± 27,03), p < 0,001; peor salud mental en R: 66,44 ± 34,30 vs. D: 47,48 ± 24,06, p < 0,001; mejor selección de alimentos en D (75,86 ± 34,12) vs. R (68,17 ± 33,60), p < 0,01. Conclusiones: definir la percepción de la QoL contribuye a una mejor comprensión de las necesidades del paciente. Es necesaria más información para afrontar sus miedos, para adecuar mejor la viscosidad de los líquidos y la textura de la dieta. Se recomienda aumentar la diversidad alimentaria en las residencias.

Prevalence of dysphagia in a regional hospital setting: Acute care hospital and a geriatric sociosanitary care hospital: A cross-sectional study.

RATIONALE: Oropharyngeal Dysphagia (OD) is a symptom commonly found in hospitalized patients and related to a vast array of clinical diagnosis and to high morbidity and mortality that is becoming very important to identify. Our aim was to assess the prevalence of OD in our hospital setting. METHODS: Cross-sectional randomized study to determine the prevalence of dysphagia in an acute care hospital (ACH) and long term care hospital (LTCH). Multiquestionnaire test performed to assess dysphagia with the bedside validated volume-viscosity swallow test (V-VST test), in those with the validated swallowing ability test, eating assessment tool (EAT-10)>3. Variables; sex, age (>65 y), diagnosis, mininutritional assessment (MNA), previous diagnosis of dysphagia (including any recommendations given before), EAT-10, V-VST, presence of dysphagia, type of diet prescribed (basal or therapeutic), use of thickener and diet texture (pureed with liquids allowed, pureed without liquids, soft diet, normal). RESULTS: N = 200 patients (100 in each centre). 49% male; Age = 81.1 [65-101] years; Diagnostics: medical 70%/surgery 30%. Dysphagia analysis: 42% patients showed an EAT-10 > 3 so the V-VST test was done in these patients resulting in global prevalence of 28.5% (95% CI: 22.7-35.1). Among centres no significant differences were observed: ACH 30% (95% CI: 14-34) and LTCH 27% (95% CI: 19-36). Highlighting a greater concentration of dysphagia in Orthogeriatric and Neurological patients in the LTCH than in ACH (Pneumology, Internal Medicine and Cardiology). MNA analysis: 27% normal 44% risk 29% malnutrition. Malnutrition present in 50.9% of patients diagnosed with dysphagia, 44% in those at risc (EAT-10 +) and 27.6% in those without risc or dysphagia (p = 0.020). From the novo patients, 75.4% did not have adequate complete adapted treatment (diet and thickener). Only 13.3% had their thickener prescribed. In those with history of dysphagia 37% had an inappropriate treatment. CONCLUSION: Prevalence of OD matches with what is described in the literature. There is a high proportion of infradiagnostic and overall inadequate treatment, more than a third of patients do not have their diet adapted correctly. It is important to identify this symptom to treat it properly and to raise awareness among sanitary professionals for best adaptation of treatment.

Malformación de Chiari tipo I como causa de disfagia orofaríngea. A propósito de un caso / Type I Chiari Malformation as a cause of oropharyngeal dysphagia. A case report

Introducción y objetivo: En este artículo se revisa un síntoma infrecuente que puede aparecer en la malformación de Chiari tipo I, la disfagia, cuya omisión puede excluir el diagnóstico o atribuirlo a otra patología. Paciente: Varón joven con cervicalgia y disfagia de 6 meses de evolución que consultó por disnea y fiebre. Ante la sospecha de neumonía broncoaspirativa se realizó una historia clínica completa y dirigida sobre las áreas topográficas que gobiernan la deglución y se realizaron toda una serie de pruebas complementarias para descartar otras causas de disfagia. La RM craneal confirmó el diagnostico de malformación de Chiari tipo I. El paciente fue intervenido quirúrgicamente mediante descompresión suboccipital. Pasados 6 meses mejoró la cervicalgia y desapareció la disfagia. Discusión: La disfagia es un síntoma inusual de la malformación de Chiari tipo I, debido a alteración por compresión del tronco encefálico y/o a elongación de los pares craneales bajos. Para lograr diagnósticos tempranos y el tratamiento adecuado, la exploración fí- sica debe ser completa y dirigida sobre las áreas topográficas que gobiernan la deglución, siendo básica la RM para establecer el diagnóstico causal. Conclusión: En pacientes con disfagia de origen incierto el diagnóstico de malformación de Chiari u otra causa de afectación de pares craneales bajos debe tenerse en cuenta (AU)

Introduction and objective: This article reviews an uncommon entity that may appear in Chiari malformation Type I, dysphagia, whose omission may exclude the diagnosis or attribute it to other pathology. Patient: Young male with dyspnea and fever who reported 6 month’s evolution neck pain and progressive dysphagia. Suspecting aspiration pneumonia, a complete and directed medical history on the topographical areas that govern swallowing and a series of additional tests, to rule out other causes of dysphagia, were held. Cranial MRI confirmed the diagnosis of type I Chiari malformation. The patient was surgically intervened through suboccipital decompression. 6 months after surgery there was an improvement in neck pain and dysphagia disappeared. Discussion: Dysphagia is an unusual symptom of type I Chiari malformation usually due to alteration by compression of the brainstem and/or to elongation of the lower cranial nerves. To achieve early diagnosis and proper treatment, the physical examination should be complete and directed over areas that govern swallowing, being MRI basic to establish causal diagnosis. Conclusion: Diagnosis of Chiari malformation or other causes of lower cranial nerves impairment must be kept in mind in patients with dysphagia of uncertain origin (AU)